# Best Clinical Endpoints That Likely Induce Worse Prognosis in Interstitial Lung Diseases

> **NCT03400839** · — · UNKNOWN · sponsor: **Universidade Estadual de Londrina** · enrollment: 105 (estimated)

## Conditions studied

- Interstitial Lung Disease

## Interventions

- **DIAGNOSTIC_TEST:** Daily physical activity levels
- **DIAGNOSTIC_TEST:** 6-minute walk test
- **DIAGNOSTIC_TEST:** Cardiopulmonary exercise testing
- **DIAGNOSTIC_TEST:** Muscle Function
- **DIAGNOSTIC_TEST:** Lung Function
- **DIAGNOSTIC_TEST:** Body composition
- **DIAGNOSTIC_TEST:** HRQoL - SGRQ-I
- **DIAGNOSTIC_TEST:** Symptoms - UCSD/SOBQ
- **DIAGNOSTIC_TEST:** HRQoL - SF36
- **DIAGNOSTIC_TEST:** Anxiety and depression
- **DIAGNOSTIC_TEST:** Symptoms - mMRC
- **DIAGNOSTIC_TEST:** Sleep quality
- **DIAGNOSTIC_TEST:** Sleepiness
- **DIAGNOSTIC_TEST:** Inflammatory markers and oxidative stress
- **DIAGNOSTIC_TEST:** Functional performance tests

## Key facts

- **NCT ID:** NCT03400839
- **Lead sponsor:** Universidade Estadual de Londrina
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-09-15
- **Primary completion:** 2023-10-01
- **Final completion:** 2023-10-01
- **Target enrollment:** 105 (ESTIMATED)
- **Last updated:** 2021-08-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03400839

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03400839, "Best Clinical Endpoints That Likely Induce Worse Prognosis in Interstitial Lung Diseases". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT03400839. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*